| 000 | 01297 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515203155.0 | ||
| 264 | 0 | _c20100329 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0214-0934 | ||
| 024 | 7 |
_a10.1358/dnp.2009.9.1428871 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Mello, Santosh R | |
| 245 | 0 | 0 |
_aHistone deacetylases as targets for the treatment of human neurodegenerative diseases. _h[electronic resource] |
| 260 |
_bDrug news & perspectives _cNov 2009 |
||
| 300 |
_a513-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Death |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHistone Deacetylases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsoenzymes |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aSirtuins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tDrug news & perspectives _gvol. 22 _gno. 9 _gp. 513-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dnp.2009.9.1428871 _zAvailable from publisher's website |
| 999 |
_c19450750 _d19450750 |
||